Skip to main content
Microbiology Spectrum logoLink to Microbiology Spectrum
. 2024 Feb 5;12(3):e03017-23. doi: 10.1128/spectrum.03017-23

Klebsiella pneumoniae ST147 harboring blaNDM-1, multidrug resistance and hypervirulence plasmids

Frederick Ofosu-Appiah 1,2,#, Ezra E Acquah 2,#, Jibril Mohammed 2, Comfort Sakyi Addo 2, Bright Agbodzi 2, Dorcas A S Ofosu 2, Charles J Myers 2, Quaneeta Mohktar 2, Opoku-Ware Ampomah 3, Anthony Ablordey 2, Nana Ama Amissah 2,
Editor: Xiaohui Zhou4
PMCID: PMC10913492  PMID: 38315028

ABSTRACT

The spread of hypervirulent (hv) and carbapenem-/multidrug-resistant Klebsiella pneumoniae is an emerging problem in healthcare settings. The New Delhi metallo-β-lactamase-1 (blaNDM-1) is found in Enterobacteriaceae including K. pneumoniae. The blaNDM-1 is capable of hydrolyzing β-lactam antibiotics which are used for treatment of severe infections caused by multidrug-resistant Gram-negative bacteria. This is associated with the unacceptably high mortality rate in immunocompromised burn injury patients. This study reports on the characterization of blaNDM-1 gene and virulence factors in hv carbapenem-/multidrug-resistant K. pneumoniae ST147 in the burns unit of a tertiary teaching hospital during routine surveillance. Two K. pneumoniae strains were obtained from wounds of burn-infected patients from May 2020 to July 2021. The hypervirulence genes and genetic context of the blaNDM-1 gene and mobile genetic elements potentially involved in the transposition of the gene were analyzed. We identified a conserved genetic background and an IS26 and open reading frame flanking the blaNDM-1 gene that could suggest its involvement in the mobilization of the gene. The plasmid harbored additional antibiotic resistance predicted regions that were responsible for resistance to almost all the routinely used antibiotics. To ensure the identification of potential outbreak strains during routine surveillance, investigations on resistance genes and their environment in relation to evolution are necessary for molecular epidemiology.

IMPORTANCE

Data obtained from this study will aid in the prompt identification of disease outbreaks including evolving resistance and virulence of the outbreak bacteria. This will help establish and implement antimicrobial stewardship programs and infection prevention protocols in fragile health systems in countries with limited resources. Integration of molecular surveillance and translation of whole-genome sequencing in routine diagnosis will provide valuable data for control of infection. This study reports for the first time a high-risk clone K. pneumoniae ST147 with hypervirulence and multidrug-resistance features in Ghana.

KEYWORDS: Klebsiella pneumoniae, multidrug resistance, blaNDM-1 gene, hypervirulence, mobile genetic elements, burn wounds

INTRODUCTION

Klebsiella pneumoniae is an important human pathogen that causes nosocomial and community-acquired infectious diseases including septicemia and respiratory, urinary tract, skin and soft tissue and pneumonia infections (1). Over time, K. pneumoniae has acquired virulence factors and antibiotic resistance important for its pathogenesis (24). These genetic features of K. pneumoniae have been identified from multiple sources such as pulmonary infection and wounds, and have been associated with dysbiosis in the gut microbiome and changes in lung metabolome (5, 6). The global emergence of New Delhi metallo-β-lactamase-1 (blaNDM-1), a class B (zinc metallo-) β-lactamase, after its first detection in Sweden in 2008 from an Indian patient, is a major public health concern (79). First discovered in K. pneumoniae and Escherichia coli, New Delhi metallo-β-lactamase-1 (blaNDM-1) has been identified in other Enterobacteriaceae including Citrobacter freundii, Enterobacter cloacae, Morganella morganii, and Proteus vulgaris (10, 11). The blaNDM-1-positive Enterobacteriaceae has been found in both hospital and community-acquired infections, food, and water sources (12). This has led to the emergence of hypervirulent (hv) and carbapenem and/or multidrug-resistant K. pneumoniae spp. that cause invasive infections including endophthalmitis and meningitis in immunocompromised patients (13). Hypervirulent K. pneumoniae (hv-KP) is associated with a variety of factors including capsular serotypes, hypermucoviscosity, sequence types (ST11 and ST23), pathogenicity island, virulence plasmid, and virulence factors such as lipopolysaccharide, type VI secretion system, siderophore production and allantoin metabolism (14). Hv-KP pathogens are responsible for pyogenic liver abscesses, osteomyelitis and endophthalmitis in younger populations in the community (15). Over 78 capsular serotypes of K. pneumoniae have been reported; K1 and K2 serotypes are the most prevalent in hv-KP (1619). Most hv-KP strains are susceptible to the commonly prescribed antibiotics, including carbapenems (20). However, these strains can acquire carbapenem or multidrug resistance that can lead to the emergence of isolates that have combined resistance and virulence. Alternatively, multidrug-resistant K. pneumoniae strain can acquire virulence plasmids (pLVPK/pVir-CR-HVKP4) (13, 21, 22). This has compromised the options for the treatment of life-threatening infections caused by K. pneumoniae with combined multidrug/carbapenem and hypervirulence factors (23).

First reported in Taiwan, hv-KP is observed in many Asian, European, and American countries, with Asian countries being endemic for several cases (2427). K. pneumoniae with combined multidrug resistance and hypervirulence factors have emerged in a few African countries including Algeria, Egypt, Kenya, and Sudan (2832). Carbapenem-/multidrug-resistant hv-KP have been reported in ST11, ST14, ST23, ST25, ST43, ST65, ST86, ST231, ST375, ST380, and ST1764, and are associated with blaNDM-1 and blaKPC-2 (3338). In Ghana, Labi et al. (39) reported that K. pneumoniae made up 49.7% of the total microorganisms of the 1.0 incidence of bloodstream infections in hospitalized neonates per 100 person days. Furthermore, multidrug-resistant K. pneumoniae incidence contributed to 3.1% of rectal flora in patients undergoing prostate biopsy (40).

Bacteria that cause invasive wound infection can lead to systemic sepsis. It is important to report on the pathogenic potential of bacteria that cause invasive wound infection in burn patients. This study characterized the genetic environment of the plasmid-borne blaNDM-1 and hypervirulence genes in K. pneumoniae ST147 obtained from the burns unit of a tertiary care hospital in Ghana. Data analyses revealed that other mechanisms may initiate transposition of the blaNDM-1 than cointegration of IS26 into the adjacent IS26 region. The information obtained together with the phenotypic data will be valuable in routine surveillance and will guide infection prevention and control in our health institutions to prevent possible outbreaks.

RESULTS

Metadata from hv multidrug-resistant K. pneumoniae strains

Metadata of patients who carried isolates 016W_16082020 and 017WC1_20082020 are presented in Table 1. Patient 016 was prescribed cefuroxime, and patient 017 was prescribed amoxiclav and cefuroxime. Antibiotic susceptibility test revealed both strains displayed multidrug-resistant phenotypes (Table 2). All isolates were phenotypically resistant to commonly used antibiotics for treatment of K. pneumoniae infections in Ghana, including amikacin, ampicillin, ampicillin/sulbactam, aztreonam, cefepime, ceftazidime, cefotaxime, cefuroxime, ciprofloxacin, doripenem, imipenem, meropenem, piperacillin, and tobramycin, and susceptible to gentamicin, tigecycline, and trimethoprim/sulfamethoxazole.

TABLE 1.

Metadata of patients colonized with hv carbapenem-/multidrug-resistant K. pneumoniae

Patient information 016 017
Age (years) 46 2
Gender Female Female
Total body surface area (%) 23 24
Cause of injury Gas Hot soup
Source of isolation Wound Wound
Antibiotics prescribed Cefuroxime Cefuroxime and amoxiclav
Duration of stay (days) 5 11
Time of admission
Patient outcome Death Death

TABLE 2.

Antimicrobial susceptibility test of hv carbapenem-/multidrug-resistant K. pneumoniae isolatesa

Antibiotics 016W_16082020 017WC1_20082020
DD/mm MIC/µg/mL DD/mm MIC (μg/mL)
Amikacin 15 < I 32 15 < I 32
Amp/sulbactam >16/8 >16/8
Amoxiclav/30 µg 6 < R 6 < R
Ampicillin >16 >16
Aztreonam >16 >16
Cefepime 10 < R >16 10 < R >16
Cefotaxime 6 < R >16 6 < R >16
Ceftazidime/30 µg 6 < R >32 6 < R >32
Cefuroxime/30 µg 6 < R >16 6 < 6 >16
Cephazolin/30 mg 6 < R 6 < R
Chloramphenicol/30 mg 6 < R 23 < S
Ciprofloxacin/5 mg 6 < R 6 < R
Clindamycin/ 2 µg 6 < R 6 < R
Colistin/ 10 µg 13 < I 13 < I
Doripenem/10 µg 16 < R >2 17 < R >2
Erythromycin/15 mg 6 < R 6 < R
Fusidic acid/10 mg 6 < R 6 < R
Gentamicin 18 > S ≤4 18 > S ≤4
Imipenem/10 µg 6 < R >8 6 < R >8
Kanamycin/30 mg 6<, R 6 < R
Meropenem >8 >8
Metronidazole/50 mg 6 < R 6 < R
Nalidixic acid/30 mg 6 < R 6 < R
Norfloxacin/10 mg 6 < R 6 < R
Piperacillin >64 >64
Rifampicin/5 mg 6 < R 6 < R
Tetracycline/30 mg 6 < R 22 < S
Tigecycline ≤2 ≤2
Tobramycin/10 mg 6 < R >8 6 < R >8
Trimeth/sulfamethoxazole 17 > S ≤2/38 18 > S ≤2/38
a

Abbreviations: DD, disk diffusion; MIC, minimum inhibitory concentration; Trimeth, trimethoprim.

K. pneumoniae ST147 phylogeny and genetic environment of blaNDM-1 and blaoxa-1 genes

Isolates 016W_16082020 and 017WC1_20082020 were assigned to ST147. A phylogenetic tree was constructed using the whole-genome single nucleotide polymorphism (SNP) phylogeny approach to compare the genetic relatedness of our isolates with other global ST147 K. pneumoniae strains (Fig. 1). Isolates 016W_16082020 and 017WC1_20082020 clustered with a Nigerian strain ERS2604946. The isolates differed by 58 and 72 SNPs, respectively. Both isolates harbored similar plasmids: IncQ and IncF and an additional plasmid IncH1 for isolate 017WC1_20082020. We compared their genetic environment to assess whether the blaNDM-1 gene from both isolates originated from a similar source and were genetically related. The blaNDM-1 gene was located on untyped plasmid pKP016W_16082020 and pKP017WC1_20082020 with plasmid sizes of 84,272 and 91,465 bp, respectively (Fig. 2). The two isolates shared a highly conserved backbone structure (Fig. 3A); however, the blaNDM-1 gene of isolate 017WC1_20082020 was oriented in the opposite direction. Both isolates were flanked upstream by an open reading frame (ORF) and downstream by the putative ancestral genes: bleMBL-iso-DsbD-cutA (Fig. 3A). These genes code for bleomycin resistance, phosphoribosylanthranilate isomerase, protein disulfide reductase, and heavy metal resistance. This segment was followed by an insertion sequence IS26. However, isolate 016W_16082020 had two copies of IS26 and bleMBL compared to 017WC1_20082020. The two isolates lacked the ISAba125, groEL, groES, tat, and IS30tnp genes when compared with KP3771 reference strain (Fig. 3A). The genetic environment surrounding the blaoxa-1 gene of both isolates shared a similar structure but in the opposite orientation. The blaoxa-1 gene was located with other resistance genes, blaoxa-1-catB-Arr-SMR-sul2-IS26 downstream for isolate 016W_16082020. Upstream contained class 1 integron with the structure of intl1-aac(6′)-Ib-cr-blaoxa-1 (Fig. 3B), while the blaoxa-1 gene of the KP3771 reference strain was flanked by the composite IS6 insertion sequence. For the class A beta-lactamase gene blaCTX-M15, it was bound upstream by the IS2 and downstream by aminoglycoside aac(6′)-Ib/aac(6′)-II and blaTEM (data not shown).

Fig 1.

Fig 1

Phylogenetic analyses of K. pneumoniae ST147 strains. The Ghana strains 016W_16082020 and 017WC1_20082020 are colored in red. Most strains are labeled with their GenBank accession, country of origin, and year of isolation. The phylogenetic tree was constructed using CSIPhylogeny pipeline and visualized in FigTree.

Fig 2.

Fig 2

Schematic representation of plasmid bearing the blaNDM-1 gene and other antibiotic-resistant predicted regions in K. pneumoniae strains (top) 016W_16082020 and (bottom) 017WC1_20082020.

Fig 3.

Fig 3

Genetic environment of beta-lactamase genes in K. pneumoniae strains. (A) Genetic structure of blaNDM-1 gene in the genomes of 016W_16082020 and 017WC1_20082020 strains in comparison with KP3771 reference strain. (B) Genetic structure of the blaoxa-1 gene in the genomes of 016W_16082020 and 017WC1_20082020 strains in comparison with KP3771 reference strain. The colored arrows denote the following: gray, mobile genetic elements including ISs and class 1 integron; green, blaNDM-1 gene; blue, antibiotic resistance genes and hypothetical genes.Abbreviations: arr, rifampin ADP ribosyl transferase; hypo, hypothetical gene; SMR, small multidrug-resistance efflux transpoter.

The pKP016W_16082020 (Fig. 2, top) and pKP017WC1_20082020 (Fig. 2, bottom) plasmids harbored predicted antibiotic resistance regions that have been shown to confer resistance to amikacin, aztreonam, cefepime, ciprofloxacin, ertapenem, fosfomycin, gentamicin, imipenem, levofloxacin, meropenem, piperacillin-tazobactam, tetracycline, tobramycin, and trimethoprim-sulfamethoxazole. Both plasmids did not contain the conjugal transfer gene.

Detection of antibiotic and virulence genes

The antibiotic resistance genes identified for both isolates coded for aminoglycosides, beta-lactams, carbapenems, cephalosporins, fluoroquinolones, phenicol, and sulfonamides (Table 3). The antibiotic resistance genes were located on untyped plasmids pKP016W_16082020 and pKP017WC1_20082020 and lacked the conjugal transfer gene (Fig. 2). A variety of hypervirulence-associated factors were identified in both K. pneumoniae strains. This includes capsule-associated genes (K64), lipopolysaccharides, type VI secretion system, fimbrial adhesin, virulence-associated regulators, siderophores (aerobactin, enterobactin, and yersiniabactin), allantoin, and efflux pumps (Table 4). Isolate 017WC1_20082020 had additional genes coding for lipopolysaccharide core biosynthesis and transport system: rfbD (o-antigen) and wzzE. These isolates tested negative for hypermucoviscosity according to the string test. The hypervirulence genes of both isolates were located on the IncQ plasmid, which harbored the conjugal transfer gene traG.

TABLE 3.

Antibiotic-resistant genes identified in hv carbapenem-/multidrug-resistant K. pneumoniae isolates

Strain Penicillins Aminoglycosides Carbapenems Cephalosporins Porin Fluoroquinolones Phenicol Sulfonamides
016W_16082020 blaOXA-1, blaOXA-9, blaTEM-190, blaTEM-1D, and blaSHV-11 aac(6′), aac(6′)-Ib-cr.aadA bla NDM-1 bla CTX-M-15 ompK35 qnrS1, gyrA-83I, and parC-80I catB3 Sul2
017WC1_20082020 blaOXA-1, blaOXA-9, and blaSHV-11 aac(6′), aac(6’)-Ib-cr.aadA bla NDM-1 bla CTX-M-15 ompK35 qnrS1, gyrA-83I, and parC-80I catB3 Sul2

TABLE 4.

Hypervirulence genes identified in hv carbapenem-/multidrug-resistant K. pneumoniae isolates

Isolates Capsular poly-saccharides Lipopolysaccharides Type VI secretion system Fimbria and adhesin Virulence-associated regulators Siderophores Allantoin metabolism Efflux pumps Plasmids
016W_16082020 K64 eptA/pmrC, heptosyltransferase I, lapB, lptA, lptB, lptC, lptD, lptE, lptF, lptG, lipid A palmitoleoytransferase pagP, lipid A biosynthesis palmitoleoytransferase, lipid A 1-diphosphate, lipid A-disaccharide synthase, msbA, ompR, rfaZ, rfbB, lipid A lauroyl acyltransferase,
lipid A-dissacharide synthase, O2a
T6SS component hcp, T6SS PAAR-repeat protein tssA, tssB, tssC, tssE, tssF, tssG, tssH, tssJ, tssK, tssL, tssM fimA, fimB, fimC, fimD, fimE, fimG, fimH, fimI, type-1 fimbrial protein, fimbrial subunit, type IV fimbrial (pilB and pilC) msgA, ompS, phoU, prmD (PhoPQ-pmrD-pmrAB) entS (enterobactin exporter), enterobactin esterase, feoB, feoA, (fyuA, psn, pesticin receptor), fepB, fepC, fepD, fepG, fieF, feoC, fur, iron acquisition 2,3-dihydroxybenzoate, iron siderophore ABC transporter, irp1, irp2, irp3, irp5, iutA, yersiniabactin (ybtA, ybtP, ybtQ, and ybtT) Allantoin, cytosine/purine/thiamine uracil ybhF, ybhG, ybhR, ybhS IncQ
017WC1_20082020 K64 eptA/pmrC, heptosyltransferase I, lapB, lptB, lptC, lptD, lptE, lptF, lptG, lipid A palmitoleoytransferase pagP, lipid A biosynthesis palmitoleoytransferase, lipid A 1-diphosphate, lipid A-disaccharide synthase, msbA, ompR, rfaZ, rfbB, rfbD (o-antigen), lipid A
lauroyl acyltransferase,
lipid A-dissacharide synthase, O2a, wzzE
T6SS component hcp, T6SS PAAR-repeat protein tssA, tssB, tssC, tssE, tssF, tssG, tssH, tssJ, tssK, tssL, tssM fimA, fimB, fimC, fimD, fimE, fimG, fimH, fimI, type 1 fimbrial protein, fimbrial subunit, type IV fimbrial (pilB and pilC) msgA, ompS, phoU, prmD (PhoPQ-pmrD-pmrAB) entS (enterobactin exporter), enterobactin esterase, feoB, feoA, (fyuA, psn, pesticin receptor), fepB, fepC, fepD, fepG, fieF, feoC, fur, iron acquisition 2,3-dihydroxybenzoate, iron siderophore ABC transporter, irp1, irp2, irp3, irp5, iutA, yersiniabactin (ybtA, ybtP, ybtQ, and ybtT) Allantoin, cytosine/purine/thiamine uracil ybhF, ybhG, ybhR, ybhS IncQ

DISCUSSION

Routine surveillance of antimicrobial-resistant (AMR) pathogens is being widely explored in low- and middle-income countries (LMICs) to inform treatment outcomes. However, genomic surveillance to monitor bacterial evolution, antimicrobial resistance, and virulence determinants over time is relatively few in LMICs (21, 4143). According to the World Health Organization’s list of AMR bacteria, K. pneumoniae has been reported as a high-priority antibiotic-resistant pathogen responsible for global nosocomial infections (44). Here, we report on the genetic environment of carbapenem-resistant blaNDM-1 gene and hypervirulence of K. pneumoniae obtained during routine surveillance in the burns unit of a tertiary teaching hospital in Ghana to gain insights into emerging high-risk clone ST147.

Extended-spectrum β-lactamase-producing K. pneumoniae ST13, ST15, ST22, ST25, ST36, ST70, ST110, ST147, ST334, ST405, ST414, ST502, and ST530 have been reported in bloodstream infections, poultry, and wounds of patients (4547). Of these, ST147 has emerged as a high-risk clone reported in hospital outbreaks globally (48). Hospital outbreaks of K. pneumoniae ST147 have been reported in China (49), Greece (50), Slovenia (51), and Tunisia (52, 53). In Africa, cases have been reported from wound infections and community samples from Algeria (32, 54), Burkina Faso (55), Egypt (56), Kenya (57, 58), Libya (59), Nigeria (60), and Tunisia (6164). Other sources such as animals from Senegal (65) and poultry products from Ghana (46) have been shown to harbor K. pneumoniae ST147. In a decade, there has been a global dissemination of ST147 high-risk clone. The close relatedness of our strains with a strain from Nigeria may suggest recent travel history of patients or contact with colonized persons in Ghana. The detection of ST147 underscores the importance of molecular surveillance in healthcare settings to prevent nosocomial outbreaks.

Carbapenem-/multidrug-resistant K. pneumoniae isolates were resistant to the prescribed antibiotics. The strains were also resistant to other antibiotics prescribed in the burns unit: ceftazidime, ciprofloxacin, imipenem, and meropenem except for gentamicin, tigecycline, and trimethoprim/sulfamethoxazole. Combination therapy for the treatment of carbapenem-resistant pathogens, including ceftazidime-avibactam, and azetreonam-avibactam, or monotherapy using cefiderocol is not the current protocol for the treatment of patients in the burns unit; hence, antimicrobial susceptibility test for these antibiotics was not tested. Due to the intermediate resistance observed, the last-resort antimicrobial, colistin, was not administered to the patients. Gentamicin and trimethoprim/sulfamethoxazole predicted resistance regions were detected; however, the strains were phenotypically susceptible at concentrations of ≤4 µg/mL and ≤2/38 µg/mL, respectively. The reasons for this observation were not explored in this study. Multidrug resistance leads to serious illness, prolonged hospital stays, and poor patient outcomes due to treatment failure. There is an urgent need to promote the appropriate use of antimicrobials to reduce microbial resistance. Hv-KP strains are highly pathogenic and known to cause invasive infections, specifically pyogenic liver abscess, meningitis, and endophthalmitis, in immunocompromised and healthy individuals (15, 66). Capsular serotypes including K5, K16, K20, K28, K54, K57, K63, K64 (identified in this study), and KN1 have been detected in hv-KP and associated with high pathogenicity and transmissibility (67, 68). The hv-KP acts by evading the host immune system, leading to severe invasive infections (19). Given the repertoire of virulence factors identified in the two carbapenem-resistant K. pneumoniae isolates, we envisage that the virulence factors could cause wound abscess, severe infection leading to sepsis, and multiple organ dysfunction syndrome, the primary cause of death in burn patients (69).

K. pneumoniae ST147 strains have acquired resistance genes on plasmids, including oxacillinases: blaoxa-48 on IncL (70), blaoxa-181 on the chromosome (71, 72), blaoxa-204 on IncA/C (73), metallo-beta-lactamase blaNDM-1 on IncFIIA (74), IncA/C (75), and IncX3 (76), and blaKPCs on pKpQIL (77) and IncN (78). Several mobile genetic elements (MGEs) such as plasmids, integrons, and transposons are associated with acquiring and transmitting carbapenem resistance genes and other AMR determinants between bacteria (79, 80). Insertion sequences (ISs) and transposons including ISAba125, IS3000, IS26, IS5, ISCR1, ISCR27, Tn3, Tn125, and Tn3000 have played vital roles in the dissemination of blaNDM genes. There has been a temporal role of plasmids, ISs, and transposons in the mobilization of blaNDM genes. First Tn125 and then Tn3000 and IS26 were involved in the transposition of the carbapenem gene (81, 82). In this study, the ST147 strains harbored the blaNDM-1 genes on plasmids pKP016W_16082020 and pKP017WC1_20082020. The IS26 was found in two positions on both plasmids about 36–52 kb apart; the second IS26 flanked blaoxa-1 in the opposite orientation, which suggests involvement in two independent activities of mobilization of antibiotic-resistant genes. Given that transposition of IS26 with the blaNDM-1 gene occurs via cointegration into the adjacent IS26 with the same orientation (83), it is unlikely that the transposition will occur successfully in our strains for the following reasons: (i) the blaNDM-1 gene was not flanked immediately on both sides by IS26 to facilitate transposition of the blaNDM-1 gene, and (ii) the orientation of the second IS26 is in the opposite direction compared to experiments shown to demonstrate mobilization of the blaNDM-1 gene. Since the blaNDM-1 gene is carried on non-conjugative plasmids, additional processes including recombination events may be involved in the transposition of the blaNDM-1 gene. Further studies are needed to improve our understanding of how IS26 pseudo-composite transposon observed in isolate 016W_16082020 will mobilize the blaNDM-1 gene to adjacent IS26 that is oriented in the opposite direction. Considering that the mobility of the blaNDM-1 gene is restricted due to the absence of the conjugal transfer gene and orientation of the second IS26, we suggest a combined role of the flanking IS26 and the ORF gene in the dissemination of the blaNDM-1 gene. Alternatively, other means of transfer, including mobilization by the virulence conjugative plasmid, IncQ (helper plasmid), or transduction by a bacteriophage, could be used to transfer the carbapenem resistance genes to other bacteria. With the high number of predicted regions for AMR, further studies are needed to demonstrate the dissemination of these genes across different bacterial genera.

Our study characterized the genetic environment and virulence factors of hypervirulent carbapenem-/multidrug-resistant K. pneumoniae strains harboring blaNDM-1 on plasmids pKP016W_16082020 and pKP017WC1_20082020 and the MGEs involved in its complex evolutionary dissemination. This highlights the virulence potential and limited options for antimicrobial therapy of patients whose wounds are infected with hv carbapenem-/multidrug-resistant K. pneumoniae strains. It is important to implement genomic surveillance in low-resource settings to promptly identify and control the spread of carbapenem resistance and monitor evolving resistant bacteria in our healthcare settings.

MATERIALS AND METHODS

Cultivation of hv multidrug-resistant K. pneumoniae and antimicrobial susceptibility

Two K. pneumoniae strains, 016W_16082020 and 017WC1_20082020, were obtained from patients in the burns unit between May 2020 and July 2021. Clinical isolates were selected from these patients because their burn injuries were infected with hv carbapenem-/multidrug-resistant K. pneumoniae. The clinical samples were cultured on MacConkey agar (Oxoid Ltd, Basingstoke, UK) and incubated at 37°C for 24 hours with the reference strain K. pneumoniae ATCC 700603. Subcultures were made on nutrient agar (Oxoid Ltd) plates supplemented with 100-μg/mL imipenem-meropenem antibiotics. Identification was done using matrix-assisted laser desorption ionization-time of flight mass spectrometry with a microflex LT Biotyper v.3.0 (Bruker; Daltonics, Bremen, Germany) according to the manufacturer’s instructions.

The minimum inhibitory concentrations of amikacin, ampicillin, ampicillin/sulbactam, amoxicillin-clavulanate, aztreonam, cefepime, ceftazidime, cefotaxime, ceftriaxone, cefuroxime, ciprofloxacin, colistin, doripenem, ertapenem, gentamicin, imipenem, meropenem, nitrofurantoin, piperacillin-tazobactam, tigecycline, tobramycin, and trimethoprim/sulfamethoxazole were determined using the broth microdilution method (84) with the MicroScan autoSCAN-4 System (Beckman Coulter, Brea, CA, USA) according to the manufacturer’s instructions. The Kirby-Bauer disk diffusion method (85) was used to test the antimicrobial susceptibility of the isolates to confirm the previous test. The results were interpreted according to the Clinical and Laboratory Standards Institute 2020 guidelines (86). The string test was performed on both isolates for detection of hypermucoviscosity (87).

Genomic sequencing and analysis

Genomic DNA of isolates was extracted using QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions and quantified using Qubit1 X dsDNA HS Assay Kit (ThermoFisher Scientific, MA USA) on the Qubit 4 Fluorometer (ThermoFisher Scientific). DNA libraries were prepared using Rapid barcoding (RQK-RBK004) and sequenced on the GridION MK1 sequencer (GXB03459) (Oxford Nanopore Technologies Ltd, Oxford Science Park, UK) (8890). All procedures of DNA preparation, library construction, and genome sequencing were done according to the manufacturer’s instructions. The pass reads were trimmed off adapter sequences using Porechop v.0.2.4. Nanofilt v.1.0.5 was used to quality-filter trimmed reads to remove reads with average quality of <9 and length shorter than 500 bp. The resultant high-quality reads were used for de novo assembly using flye v.2.8.1 and polished with medaka v.1.6.1. The phylogenetic tree was constructed using the CSIPhylogeny pipeline (https://cge.food.dtu.dk/services/CSIPhylogeny/) (91). Bactinspector v.0.1.3 was used to select an appropriate reference (CP014755.1). The tree was visualized in FigTree, and SNP distances between strains were calculated using snp-dists v.0.8.2 (https://github.com/tseemann/snp-dists). The assembled data were annotated using RAST server platform (https://rast.nmpdr.org) (92) and analyzed using Geneious Prime v.2023.0.4. The global platform for genomic surveillance, Pathogenwatch (https://pathogen.watch/), was used to predict antibiotic resistance and virulence genes including the capsule serotype (K and O).

ACKNOWLEDGMENTS

This research received no specific funding from any funding agency in the public, commercial, or not-for-profit sectors. SeqAfrica funded sequencing of the two Klebsiella pneumoniae isolates.

Contributor Information

Nana Ama Amissah, Email: namissah@ug.edu.gh.

Xiaohui Zhou, Yangzhou University, Yangzhou, China.

ETHICS APPROVAL

The study was approved by the internal review board ethics committee of the Korle Bu Teaching Hospital (KBTH-IRB/000106/2018). Verbal and written informed consent was obtained from burn patients, visitors of patients, and healthcare workers before recruitment to the study.

DATA AVAILABILITY

The sequence reads were submitted to the National Center for Biotechnology Information GenBank and are available under the BioProject number PRJNA944783 and accession numbers JARNMI000000000 and JARNMH000000000.

REFERENCES

  • 1. Gorrie CL, Mirceta M, Wick RR, Judd LM, Wyres KL, Thomson NR, Strugnell RA, Pratt NF, Garlick JS, Watson KM, Hunter PC, McGloughlin SA, Spelman DW, Jenney AWJ, Holt KE. 2018. Antimicrobial-resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital. Clin Infect Dis 67:161–170. doi: 10.1093/cid/ciy027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Lan P, Jiang Y, Zhou J, Yu Y. 2021. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist 25:26–34. doi: 10.1016/j.jgar.2021.02.020 [DOI] [PubMed] [Google Scholar]
  • 3. Perez-Palacios P, Gual-de-Torrella A, Delgado-Valverde M, Oteo-Iglesias J, Hidalgo-Díaz C, Pascual Á, Fernández-Cuenca F. 2022. Transfer of plasmids harbouring blaOXA-48-like carbapenemase genes in biofilm-growing Klebsiella pneumoniae: effect of biocide exposure. Microbiol Res 254:126894. doi: 10.1016/j.micres.2021.126894 [DOI] [PubMed] [Google Scholar]
  • 4. Chukamnerd A, Pomwised R, Jeenkeawpiam K, Sakunrang C, Chusri S, Surachat K. 2022. Genomic insights into blaNDM-carrying carbapenem-resistant Klebsiella pneumoniae clinical isolates from a university hospital in Thailand. Microbiol Res 263:127136. doi: 10.1016/j.micres.2022.127136 [DOI] [PubMed] [Google Scholar]
  • 5. Di Mento G, Gona F, Russelli G, Cuscino N, Barbera F, Carreca AP, Di Carlo D, Cardinale F, Monaco F, Campanella M, Mularoni A, Grossi P, Conaldi PG, Douradinha B. 2022. A retrospective molecular epidemiological scenario of carbapenemase-producing Klebsiella pneumoniae clinical isolates in a Sicilian transplantation hospital shows a swift polyclonal divergence among sequence types, resistome and virulome. Microbiol Res 256:126959. doi: 10.1016/j.micres.2021.126959 [DOI] [PubMed] [Google Scholar]
  • 6. Jiang Q, Xu Q, Kenéz Á, Chen S, Yang G. 2022. Klebsiella pneumoniae infection is associated with alterations in the gut microbiome and lung metabolome. Microbiol Res 263:127139. doi: 10.1016/j.micres.2022.127139 [DOI] [PubMed] [Google Scholar]
  • 7. Nordmann P, Poirel L, Walsh TR, Livermore DM. 2011. The emerging NDM carbapenemases. Trends Microbiol 19:588–595. doi: 10.1016/j.tim.2011.09.005 [DOI] [PubMed] [Google Scholar]
  • 8. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. 2009. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054. doi: 10.1128/AAC.00774-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Hammerum AM, Toleman MA, Hansen F, Kristensen B, Lester CH, Walsh TR, Fuursted K. 2010. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 10:829–830. doi: 10.1016/S1473-3099(10)70276-0 [DOI] [PubMed] [Google Scholar]
  • 10. Kong LH, Xiang R, Wang YL, Wu SK, Lei CW, Kang ZZ, Chen YP, Ye XL, Lai Y, Wang HN. 2020. Integration of the blaNDM-1 carbapenemase gene into a novel SXT/R391 integrative and conjugative element in Proteus vulgaris. J Antimicrob Chemother 75:1439–1442. doi: 10.1093/jac/dkaa068 [DOI] [PubMed] [Google Scholar]
  • 11. Wang X, Chen G, Wu X, Wang L, Cai J, Chan EW, Chen S, Zhang R. 2015. Increased prevalence of carbapenem resistant Enterobacteriaceae in hospital setting due to cross-species transmission of the blaNDM-1 element and clonal spread of progenitor resistant strains. Front Microbiol 6:595. doi: 10.3389/fmicb.2015.00595 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17:1791–1798. doi: 10.3201/eid1710.110655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Marr CM, Russo TA. 2019. Hypervirulent Klebsiella pneumoniae: a new public health threat. Expert Rev Anti-infect Ther 17:71–73. doi: 10.1080/14787210.2019.1555470 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Lee C-R, Lee JH, Park KS, Jeon JH, Kim YB, Cha C-J, Jeong BC, Lee SH. 2017. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front Cell Infect Microbiol 7:483. doi: 10.3389/fcimb.2017.00483 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Zhao B, Hu R, Gong L, Wang X, Zhu Y, Wu G. 2021. Pyogenic liver abscess and endogenous endophthalmitis due to K64-ST1764 hypervirulent Klebsiella pneumoniae: a case report. Infect Drug Resist 14:71–77. doi: 10.2147/IDR.S289088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Catalán-Nájera JC, Garza-Ramos U, Barrios-Camacho H. 2017. Hypervirulence and hypermucoviscosity: two different but complementary Klebsiella spp. phenotypes? Virulence 8:1111–1123. doi: 10.1080/21505594.2017.1317412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Wyres KL, Wick RR, Gorrie C, Jenney A, Follador R, Thomson NR, Holt KE. 2016. Identification of Klebsiella capsule synthesis loci from whole genome data. Microb Genom 2:e000102. doi: 10.1099/mgen.0.000102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Pan YJ, Fang HC, Yang HC, Lin TL, Hsieh PF, Tsai FC, Keynan Y, Wang JT. 2008. Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. J Clin Microbiol 46:2231–2240. doi: 10.1128/JCM.01716-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Paczosa MK, Mecsas J. 2016. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev 80:629–661. doi: 10.1128/MMBR.00078-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Tang M, Li J, Liu Z, Xia F, Min C, Hu Y, Wang H, Zou M. 2023. Clonal transmission of polymyxin B-resistant hypervirulent Klebsiella pneumoniae isolates coharboring blaNDM-1 and blaKPC-2 in a tertiary hospital in China. BMC Microbiol 23:64. doi: 10.1186/s12866-023-02808-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Gu D, Dong N, Zheng Z, Lin D, Huang M, Wang L, Chan EWC, Shu L, Yu J, Zhang R, Chen S. 2018. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis 18:37–46. doi: 10.1016/S1473-3099(17)30489-9 [DOI] [PubMed] [Google Scholar]
  • 22. Liu C, Du P, Xiao N, Ji F, Russo TA, Guo J. 2020. Hypervirulent Klebsiella pneumoniae is emerging as an increasingly prevalent K. pneumoniae pathotype responsible for nosocomial and healthcare-associated infections in Beijing, China. Virulence 11:1215–1224. doi: 10.1080/21505594.2020.1809322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Feng Y, Lu Y, Yao Z, Zong Z. 2018. Carbapenem-resistant hypervirulent Klebsiella pneumoniae of sequence type 36. Antimicrob Agents Chemother 62:e02644-17. doi: 10.1128/AAC.02644-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Cubero M, Grau I, Tubau F, Pallarés R, Dominguez MA, Liñares J, Ardanuy C. 2016. Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007-2013). Clin Microbiol Infect 22:154–160. doi: 10.1016/j.cmi.2015.09.025 [DOI] [PubMed] [Google Scholar]
  • 25. El Fertas-Aissani R, Messai Y, Alouache S, Bakour R. 2013. Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathol Biol (Paris) 61:209–216. doi: 10.1016/j.patbio.2012.10.004 [DOI] [PubMed] [Google Scholar]
  • 26. Pereira SCL, Vanetti MCD. 2015. Potential virulence of Klebsiella sp. isolates fromenteral diets. Braz J Med Biol Res 48:782–789. doi: 10.1590/1414-431X20154316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Peirano G, Pitout JDD, Laupland KB, Meatherall B, Gregson DB. 2013. Population-based surveillance for hypermucoviscosity Klebsiella pneumoniae causing community-acquired bacteremia in Calgary, Alberta. Can J Infect Dis Med Microbiol 24:e61–e64. doi: 10.1155/2013/828741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Ahmed M-G-S, Yang Y, Yang Y, Yan B, Chen G, Hassan RM, Zhong L-L, Chen Y, Roberts AP, Wu Y, He R, Liang X, Qin M, Dai M, Zhang L, Li H, Yang F, Xu L, Tian G-B. 2021. Emergence of hypervirulent carbapenem-resistant Klebsiella pneumoniae coharboring a blaNDM-1-carrying virulent plasmid and a blaKPC-2-carrying plasmid in an Egyptian hospital. mSphere 6:e00088-21. doi: 10.1128/mSphere.00088-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Yang Y, Yang Y, Ahmed M, Qin M, He R, Wu Y, Liang X, Zhong LL, Chen P, Deng B, Hassan RM, Wen W, Xu L, Huang X, Xu L, Tian GB. 2022. Carriage of distinct blaKPC-2 and blaOXA-48 plasmids in a single ST11 hypervirulent Klebsiella pneumoniae isolate in Egypt. BMC Genomics 23:20. doi: 10.1186/s12864-021-08214-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Albasha AM, Osman EH, Abd-Alhalim S, Alshaib EF, Al-Hassan L, Altayb HN. 2020. Detection of several carbapenems resistant and virulence genes in classical and hyper-virulent strains of Klebsiella pneumoniae isolated from hospitalized neonates and adults in Khartoum. BMC Res Notes 13:312. doi: 10.1186/s13104-020-05157-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Osman EA, Yokoyama M, Altayb HN, Cantillon D, Wille J, Seifert H, Higgins PG, Al-Hassan L. 2023. Klebsiella pneumonia in Sudan: multidrug resistance, polyclonal dissemination, and virulence. Antibiotics (Basel) 12:233. doi: 10.3390/antibiotics12020233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Zemmour A, Dali-Yahia R, Maatallah M, Saidi-Ouahrani N, Rahmani B, Benhamouche N, Al-Farsi HM, Giske CG. 2021. High-risk clones of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from the university hospital establishment of Oran, Algeria (2011-2012). PLoS One 16:e0254805. doi: 10.1371/journal.pone.0254805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L, Grimont P. 2009. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4:e4982. doi: 10.1371/journal.pone.0004982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Decré D, Verdet C, Emirian A, Le Gourrierec T, Petit JC, Offenstadt G, Maury E, Brisse S, Arlet G. 2011. Emerging severe and fatal infections due to Klebsiella pneumoniae in two university hospitals in France. J Clin Microbiol 49:3012–3014. doi: 10.1128/JCM.00676-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Compain F, Vandenberghe A, Gominet M, Genel N, Lebeaux D, Ramahefasolo A, Podglajen I, Decré D. 2017. Primary osteomyelitis caused by an NDM-1-producing K. pneumoniae strain of the highly virulent sequence type 23. Emerg Microbes Infect 6:1–3. doi: 10.1038/emi.2017.43 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Liu Z, Gu Y, Li X, Liu Y, Ye Y, Guan S, Li J. 2019. Identification and characterization of NDM-1-producing hypervirulent (hypermucoviscous) Klebsiella pneumoniae in China. Ann Lab Med 39:167–175. doi: 10.3343/alm.2019.39.2.167 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Mei Y, Liu P, Wan L-G, Liu Y, Wang L, Wei D, Deng Q, Cao X. 2017. Virulence and genomic feature of a virulent Klebsiella pneumoniae sequence type 14 strain of serotype K2 harboring blaNDM-5 in China. Front Microbiol 8:229842. doi: 10.3389/fmicb.2017.00335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Wei DD, Wan LG, Liu Y. 2018. Draft genome sequence of an NDM-1- and KPC-2-coproducing hypervirulent carbapenem-resistant Klebsiella pneumoniae strain isolated from burn wound infections. Genome Announc 6:e00192-18. doi: 10.1128/genomeA.00192-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Labi AK, Enweronu-Laryea CC, Nartey ET, Bjerrum S, Ayibor PK, Andersen LP, Newman MJ, Kurtzhals JAL. 2021. Bloodstream infections at two neonatal intensive care units in Ghana: multidrug resistant enterobacterales undermine the usefulness of standard antibiotic regimes. Pediatr Infect Dis J 40:1115–1121. doi: 10.1097/INF.0000000000003284 [DOI] [PubMed] [Google Scholar]
  • 40. Labi AK, Obeng-Nkrumah N, Dayie N, Addo BM, Osei MM, Fenny A, Egyir B, Mensah JE. 2022. Occurrence and significance of fluoroquinolone-resistant and ESBL-producing Escherichia coli and Klebsiella pneumoniae complex of the rectal flora in Ghanaian patients undergoing prostate biopsy. JAC Antimicrob Resist 4:dlac113. doi: 10.1093/jacamr/dlac113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Qin X, Wu S, Hao M, Zhu J, Ding B, Yang Y, Xu X, Wang M, Yang F, Hu F. 2020. The colonization of carbapenem-resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis 221:S206–S214. doi: 10.1093/infdis/jiz622 [DOI] [PubMed] [Google Scholar]
  • 42. Roberts LW, Hoi LT, Khokhar FA, Hoa NT, Giang TV, Bui C, Ninh TH, Co DX, Binh NG, Long HB, Huong DT, Bryan JE, Herrick A, Feltwell T, Nadjm B, van Doorn HR, Parkhill J, Trung NV, Kinh NV, Iqbal Z, Török ME. 2022. Genomic characterisation of multidrug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two intensive care units in Hanoi, Viet Nam: a prospective observational cohort study. Lancet Microbe 3:e857–e866. doi: 10.1016/S2666-5247(22)00181-1 [DOI] [PubMed] [Google Scholar]
  • 43. Perovic O, Singh-Moodley A, Lowe M. 2023. In vitro activity of ceftolozane-tazobactam against Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa obtained from blood cultures from sentinel public hospitals in South Africa. Antibiotics 12:453. doi: 10.3390/antibiotics12030453 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. CDC . 2019. Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services, Atlanta, GA. [Google Scholar]
  • 45. Eibach D, Belmar Campos C, Krumkamp R, Al-Emran HM, Dekker D, Boahen KG, Kreuels B, Adu-Sarkodie Y, Aepfelbacher M, Park SE, Panzner U, Marks F, May J. 2016. Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012. Int J Med Microbiol 306:249–254. doi: 10.1016/j.ijmm.2016.05.006 [DOI] [PubMed] [Google Scholar]
  • 46. Eibach D, Dekker D, Gyau Boahen K, Wiafe Akenten C, Sarpong N, Belmar Campos C, Berneking L, Aepfelbacher M, Krumkamp R, Owusu-Dabo E, May J. 2018. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in local and imported poultry meat in Ghana. Vet Microbiol 217:7–12. doi: 10.1016/j.vetmic.2018.02.023 [DOI] [PubMed] [Google Scholar]
  • 47. Agyekum A, Fajardo-Lubián A, Ansong D, Partridge SR, Agbenyega T, Iredell JR. 2016. blaCTX-M-15 carried by IncF-type plasmids is the dominant ESBL gene in Escherichia coli and Klebsiella pneumoniae at a hospital in Ghana. Diagn Microbiol Infect Dis 84:328–333. doi: 10.1016/j.diagmicrobio.2015.12.010 [DOI] [PubMed] [Google Scholar]
  • 48. Peirano G, Chen L, Kreiswirth BN, Pitout JDD. 2020. Emerging antimicrobial-resistant high-risk Klebsiella pneumoniae clones ST307 and ST147. Antimicrob Agents Chemother 64:e01148-20. doi: 10.1128/AAC.01148-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Zou H, Shen Y, Li C, Li Q. 2022. Two phenotypes of Klebsiella pneumoniae ST147 outbreak from neonatal sepsis with a slight increase in virulence. Infect Drug Resist 15:1–12. doi: 10.2147/IDR.S343292 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Protonotariou E, Poulou A, Politi L, Sgouropoulos I, Metallidis S, Kachrimanidou M, Pournaras S, Tsakris A, Skoura L. 2018. Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece. Int J Antimicrob Agents 52:331–337. doi: 10.1016/j.ijantimicag.2018.04.004 [DOI] [PubMed] [Google Scholar]
  • 51. Pirš M, Cerar Kišek T, Križan Hergouth V, Seme K, Mueller Premru M, Jeverica S, Logar M, Mrvič T, Žnidaršič B, Jordan Markočič O, Lejko Zupanc T. 2019. Successful control of the first OXA-48 and/or NDM carbapenemase-producing Klebsiella pneumoniae outbreak in Slovenia 2014–2016. J Hosp Infect 101:142–149. doi: 10.1016/j.jhin.2018.10.022 [DOI] [PubMed] [Google Scholar]
  • 52. Messaoudi A, Haenni M, Mansour W, Saras E, Bel Haj Khalifa A, Chaouch C, Naija W, Boujâafar N, Bouallègue O, Madec J-Y. 2017. ST147 NDM-1-producing Klebsiella pneumoniae spread in two Tunisian hospitals. J Antimicrob Chemother 72:315–316. doi: 10.1093/jac/dkw401 [DOI] [PubMed] [Google Scholar]
  • 53. Hamzaoui Z, Ocampo-Sosa A, Maamar E, Fernandez Martinez M, Ferjani S, Hammami S, Harbaoui S, Genel N, Arlet G, Saidani M, Slim A, Boutiba-Ben Boubaker I, Martinez-Martinez L. 2018. An outbreak of NDM-1-producing Klebsiella pneumoniae, associated with OmpK35 and OmpK36 porin loss in Tunisia. Microb Drug Resist 24:1137–1147. doi: 10.1089/mdr.2017.0165 [DOI] [PubMed] [Google Scholar]
  • 54. Abderrahim A, Djahmi N, Pujol C, Nedjai S, Bentakouk MC, Kirane-Gacemi D, Dekhil M, Sotto A, Lavigne JP, Pantel A. 2017. First case of NDM-1-producing Klebsiella pneumoniae in Annaba university hospital, Algeria. Microb Drug Resist 23:895–900. doi: 10.1089/mdr.2016.0213 [DOI] [PubMed] [Google Scholar]
  • 55. Sanou S, Ouedraogo AS, Aberkane S, Vendrell J, Ouchar O, Bouzimbi N, Hema A, Poda A, Zoungrana J, Ouedraogo GA, Carrière C, Jean-Pierre H, Ouedraogo-Traore R, Godreuil S. 2021. Prevalence and molecular characterization of extended spectrum β-lactamase, plasmid-mediated quinolone resistance, and carbapenemase-producing Gram-negative bacilli in Burkina Faso. Microb Drug Resist 27:18–24. doi: 10.1089/mdr.2020.0134 [DOI] [PubMed] [Google Scholar]
  • 56. Sherif M, Palmieri M, Mirande C, El-Mahallawy H, Rashed HG, Abd-El-Reheem F, El-Manakhly AR, Abdel-Latif RAR, Aboulela AG, Saeed LY, Abdel-Rahman S, Elsayed E, van Belkum A, El-Kholy A. 2021. Whole-genome sequencing of Egyptian multidrug-resistant Klebsiella pneumoniae isolates: a multi-center pilot study. Eur J Clin Microbiol Infect Dis 40:1451–1460. doi: 10.1007/s10096-021-04177-7 [DOI] [PubMed] [Google Scholar]
  • 57. Muraya A, Kyany’a C, Kiyaga S, Smith HJ, Kibet C, Martin MJ, Kimani J, Musila L. 2022. Antimicrobial resistance and virulence characteristics of Klebsiella pneumoniae isolates in Kenya by whole-genome sequencing. Pathogens 11:545. doi: 10.3390/pathogens11050545 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Musila L, Kyany’a C, Maybank R, Stam J, Oundo V, Sang W. 2021. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target Gram-negative bacteria in Kenya. PLoS One 16:e0246937. doi: 10.1371/journal.pone.0246937 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Lafeuille E, Decré D, Mahjoub-Messai F, Bidet P, Arlet G, Bingen E. 2013. OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients. Microb Drug Resist 19:491–497. doi: 10.1089/mdr.2012.0219 [DOI] [PubMed] [Google Scholar]
  • 60. Olalekan A, Onwugamba F, Iwalokun B, Mellmann A, Becker K, Schaumburg F. 2020. High proportion of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among extended-spectrum β-lactamase-producers in Nigerian hospitals. J Glob Antimicrob Resist 21:8–12. doi: 10.1016/j.jgar.2019.09.007 [DOI] [PubMed] [Google Scholar]
  • 61. Grami R, Mansour W, Ben Haj Khalifa A, Dahmen S, Chatre P, Haenni M, Aouni M, Madec JY. 2016. Emergence of ST147 Klebsiella pneumoniae producing OXA-204 carbapenemase in a university hospital, Tunisia. Microb Drug Resist 22:137–140. doi: 10.1089/mdr.2014.0278 [DOI] [PubMed] [Google Scholar]
  • 62. Messaoudi A, Haenni M, Bouallègue O, Saras E, Chatre P, Chaouch C, Boujâafar N, Mansour W, Madec JY. 2020. Dynamics and molecular features of OXA-48-like-producing Klebsiella pneumoniae lineages in a Tunisian hospital. J Glob Antimicrob Resist 20:87–93. doi: 10.1016/j.jgar.2019.07.005 [DOI] [PubMed] [Google Scholar]
  • 63. Ouertani R, Limelette A, Guillard T, Brasme L, Jridi Y, Barguellil F, El Salabi A, de Champs C, Chouchani C. 2016. First report of nosocomial infection caused by Klebsiella pneumoniae ST147 producing OXA-48 and VEB-8 β-lactamases in Tunisia. J Glob Antimicrob Resist 4:53–56. doi: 10.1016/j.jgar.2015.10.002 [DOI] [PubMed] [Google Scholar]
  • 64. Mansour W, Grami R, Jaidane N, Messaoudi A, Charfi K, Ben Romdhane L, Bel Haj Khalifa A, Khedher M, Boujaafar N, Bouallègue O, Mammeri H. 2019. Epidemiology and whole-genome analysis of NDM-1-producing Klebsiella pneumoniae KP3771 from Tunisia. Microbial Drug Resist 25:644–651. doi: 10.1089/mdr.2018.0204 [DOI] [PubMed] [Google Scholar]
  • 65. Baron SA, Mediannikov O, Abdallah R, Kuete Yimagou E, Medkour H, Dubourg G, Elamire Y, Afouda P, Ngom II, Angelakis E, Davoust B, Diatta G, Barciela A, Hernandez-Aguilar RA, Sokhna C, Caputo A, Levasseur A, Rolain J-M, Raoult D. 2021. Multidrug-resistant Klebsiella pneumoniae clones from wild chimpanzees and termites in Senegal. Antimicrob Agents Chemother 65:e0255720. doi: 10.1128/AAC.02557-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM, Andersen PS, Driebe EM, Keim P, Krogfelt KA. 2015. Mapping the evolution of hypervirulent Klebsiella pneumoniae. mBio 6:e00630. doi: 10.1128/mBio.00630-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. de Campos TA, Gonçalves LF, Magalhães KG, de Paulo Martins V, Pappas Júnior GJ, Peirano G, Pitout JDD, Gonçalves GB, Furlan JPR, Stehling EG, Pitondo-Silva A. 2018. A fatal bacteremia caused by hypermucousviscous KPC-2 producing extensively drug-resistant K64-ST11 Klebsiella pneumoniae in Brazil. Front Med 5:390610. doi: 10.3389/fmed.2018.00265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Zhang Y, Jin L, Ouyang P, Wang Q, Wang R, Wang J, Gao H, Wang X, Wang H, Kang H, et al. 2020. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother 75:327–336. doi: 10.1093/jac/dkz446 [DOI] [PubMed] [Google Scholar]
  • 69. Zhang P, Zou B, Liou YC, Huang C. 2021. The pathogenesis and diagnosis of sepsis post burn injury. Burns Trauma 9:tkaa047. doi: 10.1093/burnst/tkaa047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Liapis E, Pantel A, Robert J, Nicolas-Chanoine M-H, Cavalié L, van der Mee-Marquet N, de Champs C, Aissa N, Eloy C, Blanc V, Guyeux C, Hocquet D, Lavigne J-P, Bertrand X, ONERBA . 2014. Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France. Clin Microbiol Infect 20:1121–1123. doi: 10.1111/1469-0691.12727 [DOI] [PubMed] [Google Scholar]
  • 71. Rojas LJ, Hujer AM, Rudin SD, Wright MS, Domitrovic TN, Marshall SH, Hujer KM, Richter SS, Cober E, Perez F, Adams MD, van Duin D, Bonomo RA. 2017. NDM-5 and OXA-181 beta-lactamases, a significant threat continues to spread in the Americas. Antimicrob Agents Chemother 61:e00454-17. doi: 10.1128/AAC.00454-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Sonnevend Á, Ghazawi A, Hashmey R, Haidermota A, Girgis S, Alfaresi M, Omar M, Paterson DL, Zowawi HM, Pál T. 2017. Multihospital occurrence of pan-resistant Klebsiella pneumoniae sequence type 147 with an ISEcp1-directed blaOXA-181 insertion in the mgrB gene in the United Arab Emirates. Antimicrob Agents Chemother 61:e00418-17. doi: 10.1128/AAC.00418-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Potron A, Bernabeu S, Cuzon G, Pontiès V, Blanchard H, Seringe E, Naas T, Nordmann P, Dortet L. 2017. Analysis of OXA-204 carbapenemase-producing Enterobacteriaceae reveals possible endoscopy-associated transmission, France, 2012 to 2014. Euro Surveill. 22:17-00048. doi: 10.2807/1560-7917.ES.2017.22.49.17-00048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Peirano G, Pillai DR, Pitondo-Silva A, Richardson D, Pitout JDD. 2011. The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn Microbiol Infect Dis 71:106–109. doi: 10.1016/j.diagmicrobio.2011.06.013 [DOI] [PubMed] [Google Scholar]
  • 75. Giske CG, Fröding I, Hasan CM, Turlej-Rogacka A, Toleman M, Livermore D, Woodford N, Walsh TR. 2012. Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom. Antimicrob Agents Chemother 56:2735–2738. doi: 10.1128/AAC.06142-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Wang X, Xu X, Li Z, Chen H, Wang Q, Yang P, Zhao C, Ni M, Wang H. 2014. An outbreak of a nosocomial NDM-1-producing Klebsiella pneumoniae ST147 at a teaching hospital in mainland China. Microbial Drug Resist 20:144–149. doi: 10.1089/mdr.2013.0100 [DOI] [PubMed] [Google Scholar]
  • 77. Giakkoupi P, Papagiannitsis CC, Miriagou V, Pappa O, Polemis M, Tryfinopoulou K, Tzouvelekis LS, Vatopoulos AC. 2011. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009–10). J Antimicrob Chemother 66:1510–1513. doi: 10.1093/jac/dkr166 [DOI] [PubMed] [Google Scholar]
  • 78. Rodrigues C, Bavlovič J, Machado E, Amorim J, Peixe L, Novais Â. 2016. KPC-3-producing Klebsiella pneumoniae in Portugal linked to previously circulating non-CG258 lineages and uncommon genetic platforms (Tn4401d-IncFIA and Tn4401d-IncN). Front Microbiol 7:1000. doi: 10.3389/fmicb.2016.01000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Alekshun MN, Levy SB. 2007. Molecular mechanisms of antibacterial multidrug resistance. Cell 128:1037–1050. doi: 10.1016/j.cell.2007.03.004 [DOI] [PubMed] [Google Scholar]
  • 80. Muniesa M, García A, Miró E, Mirelis B, Prats G, Jofre J, Navarro F. 2004. Bacteriophages and diffusion of β-lactamase genes. Emerg Infect Dis 10:1134–1137. doi: 10.3201/eid1006.030472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Campos JC, da Silva MJF, dos Santos PRN, Barros EM, Pereira M de O, Seco BMS, Magagnin CM, Leiroz LK, de Oliveira TGM, de Faria-Júnior C, Cerdeira LT, Barth AL, Sampaio SCF, Zavascki AP, Poirel L, Sampaio JLM. 2015. Characterization of Tn3000, a transposon responsible for blaNDM-1 dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India. Antimicrob Agents Chemother 59:7387–7395. doi: 10.1128/AAC.01458-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Harmer CJ, Moran RA, Hall RM, Bush K. 2014. Movement of IS26-associated antibiotic resistance genes occurs via a translocatable unit that includes a single IS26 and preferentially inserts adjacent to another IS26. mBio 5:e01801-14. doi: 10.1128/mBio.01801-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Harmer C.J, Pong CH, Hall RM. 2020. Structures bounded by directly-oriented members of the IS26 family are pseudo-compound transposons. Plasmid 111:102530. doi: 10.1016/j.plasmid.2020.102530 [DOI] [PubMed] [Google Scholar]
  • 84. Wassmann CS, Rolsted AP, Lyngsie MC, Torres-Puig S, Kronborg T, Vestergaard M, Ingmer H, Pontoppidan SP, Klitgaard JK. 2022. The menaquinone pathway is important for susceptibility of Staphylococcus aureus to the antibiotic adjuvant, cannabidiol. Microbiol Res 257:126974. doi: 10.1016/j.micres.2022.126974 [DOI] [PubMed] [Google Scholar]
  • 85. Jo J, Ko KS, Chase Prokesch B. 2021. Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii. Microbiol Spectr 9:e0101021. doi: 10.1128/Spectrum.01010-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. CLSI . 2020. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. Clinical and Laboratory Standards Institute. [Google Scholar]
  • 87. Kumabe A, Kenzaka T. 2014. String test of hypervirulent Klebsiella pneumonia. QJM 107:1053–1053. doi: 10.1093/qjmed/hcu124 [DOI] [PubMed] [Google Scholar]
  • 88. Akaçin İ, Ersoy Ş, Doluca O, Güngörmüşler M. 2022. Comparing the significance of the utilization of next generation and third generation sequencing technologies in microbial metagenomics. Microbiol Res 264:127154. doi: 10.1016/j.micres.2022.127154 [DOI] [PubMed] [Google Scholar]
  • 89. Lin B, Hui J, Mao H. 2021. Nanopore technology and its applications in gene sequencing. Biosensors (Basel) 11:214. doi: 10.3390/bios11070214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Wang Y, Zhao Y, Bollas A, Wang Y, Au KF. 2021. Nanopore sequencing technology, bioinformatics and applications. Nat Biotechnol 39:1348–1365. doi: 10.1038/s41587-021-01108-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Kaas RS, Leekitcharoenphon P, Aarestrup FM, Lund O. 2014. Solving the problem of comparing whole bacterial genomes across different sequencing platforms. PLoS One 9:e104984. doi: 10.1371/journal.pone.0104984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, et al. 2008. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75. doi: 10.1186/1471-2164-9-75 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The sequence reads were submitted to the National Center for Biotechnology Information GenBank and are available under the BioProject number PRJNA944783 and accession numbers JARNMI000000000 and JARNMH000000000.


Articles from Microbiology Spectrum are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES